# A Study to Look at Tapentadol Tablets in Children and Adolescents in Pain

> **NCT02151682** · PHASE2,PHASE3 · COMPLETED · sponsor: **Grünenthal GmbH** · enrollment: 73 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Tapentadol prolonged release
- **DRUG:** Morphine prolonged release

## Key facts

- **NCT ID:** NCT02151682
- **Lead sponsor:** Grünenthal GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04-29
- **Primary completion:** 2017-10-18
- **Final completion:** 2018-10-15
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2019-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02151682

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02151682, "A Study to Look at Tapentadol Tablets in Children and Adolescents in Pain". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02151682. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*